Similarly in another study, researchers identified a heterogeneous pattern of genomic alterations in ctDNA of patients with metastatic CRC including mutations in BRAF, KRAS, NRAS, MAP2K1, PIK3CA, ERBB2, MET, and EGFR genes (19). The gene discussed is ERBB2; the disease is colorectal carcinoma.